Simple fluorescent pyrimidine analogues detect the presence of DNA abasic sites

Journal of the American Chemical Society

Volumn 127, Issue 31, 2005, Pages 10784-10785

  Greco, Nicholas J ^a   Tor, Yitzhak ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PYRIMIDINE DERIVATIVE;

ABSORPTION SPECTROPHOTOMETRY; ARTICLE; BINDING SITE; FLAME PHOTOMETRY; FLUORESCENCE; NUCLEOTIDE SEQUENCE; PYRIMIDINE SYNTHESIS;

DNA; NUCLEIC ACID DENATURATION; PYRIMIDINES; SPECTROMETRY, FLUORESCENCE;

EID: 23744450315     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja052000a     Document Type: Article

References (43)

1. For review articles, see: (a) Wojczewski, C.; Stolze, K.; Engels, J. W. Synlett 1999, 1667-1678.
2. (b) Hawkins, M. E. Cell Biochem. Biophys. 2001, 34, 257-281.
3. (c) Rist, M. J.; Marino, J. P. Curr. Org. Chem. 2002, 6, 775-793.
4. Ward, D. C.; Reich, E.; Stryer, L. J. Biol. Chem. 1969, 244, 1228-1237.
5. 5-methylpyrimidin-2-one is another example. See: (a) Wu, P.; Nordlund, T. M.; Gildea, B.; McLaughlin, L. W. Biochemistry 1990, 29, 6508-6514.
6. (b) Singleton, S. F.; Shan, F.; Kanan, M. W.; McIntosh, C. M.; Stearman, C. J.; Helm, J. S.; Webb, K. J. Org. Lett. 2001, 3, 3919-3922.
7. (a) Secrist, J. A., III; Barrio, J. R.; Leonard, N. J. Science 1972, 175. 646-647.
8. (b) Holmén, A.; Albinsson, B.; Nordén, B. J. Phys. Chem. 1994, 98, 13460-13469.
9. For benzo[g]quinazoline-2,4-(1H,3H)-dione, see: (a) Godde, F.; Toulmé, J.-J.; Moreau, S. Biochemistry 1998, 37, 13765-13775.
10. (b) Arzumanov, A.; Godde, F.; Moreau, S.; Toulmé, J.-J.; Weeds, A.; Gait, M. J. Helv. Chim. Acta 2000, 83, 1424-1436.
11. (a) Ren, R. X.-F.; Chaudhuri, N. C.; Paris, P. L.; Rumney, S., IV; Kool, E. T. J. Am. Chem. Soc. 1996, 118, 7671-7678.
12. (b) Strässler, C.; Davis, N. E.; Kool, E. T. Helv. Chim. Acta 1999, 82, 2160-2171.
13. (a) Netzel, T. L.; Zhao, M.; Nafisik, K.; Headrick, J.; Sigman, M. S.; Eaton, B. E. J. Am. Chem. Soc. 1995, 117, 9119-9128.
14. (b) Kerr, C. E.; Mitchell, C. D.; Headrick, J.; Eaton, B. E.; Netzel, T. L. J. Phys. Chem. B 2000, 104, 1637-1650.
15. (c) Seela, F.; Zulauf, M.; Sauer, M.; Deimel, M. Helv. Chim. Acta 2000, 83, 910-927.
16. (d) Seela, F.; Felling, E.; Gross, J.; Hillenkamp, F.; Ramzaeva, N.; Rosemeyer, H.; Zulauf, M. J. Biotechnol. 2001, 86, 269-279.
17. Hurley, D. J.; Seaman, S. E.; Mazura, J. C.; Tor, Y. Org. Lett. 2002, 4, 2305-2308.
18. See Supporting Information for experimental details.
19. Previous synthesis of 2a, 2b, and 2d: (a) Wigerinck, P.; Pannecouque, C.; Snoeck, R.; Claes, P.; De Clercq, E.; Herdewijn, P. J. Med Chem. 1991, 34, 2383-2389. 2d:
20. (b) Gutierrez, A. J.; Terhorst, T. J.; Matteucci, M. D.; Froehler, B. C. J. Am. Chem. Soc. 1994, 116, 5540-5544.
21. Commercial availability of 5-iodouridine makes RNA analogues possible.
22. 9
23. Aqueous buffer = 0.01 M sodium phosphate, 0.1 M NaCl, pH = 7.0.
24. This behavior typically occurs in polar molecules that are likely to have enlarged dipoles and charge-transfer character in their excited state.
25. 9
26. 9 (18) Irreversible abasic site detection: (a) Weinfeld, M.; Liuzzi, M.; Paterson, M. C. Biochemistry 1990, 29, 1737-1743.
27. (b) Kubo, K.; Ide, H.; Wallace, S. S.; Kow, Y. W. Biochemistry 1992, 31, 3703-3708.
28. (c) Lhomme, J.; Constant, J.-F.; Demeunynck, M. Biopolymers 2000, 52, 65-83.
29. (d) Atamna, H.; Cheung, I.; Ames, B. N. Proc. Natl. Acad. Sci. U.S.A. 2000. 97, 686-691.
30. (e) Bowman, K. J.; Le Pla, R.; Guichard, Y.; Farmer, P. B.; Jones, G. D. D. Nucleic Acids Res. 2001, 29. e101.
31. (f) Sun, H. B.; Qian, L.; Yokota, H. Anal. Chem. 2001, 73, 2229-2232.
32. (g) Georgakilas, A. G.; Bennett, P. V.; Sutherland, B. M. Nucleic Acids Res. 2002, 30, 2800-2808.
33. (h) Zhang, L.-K.; Gross, M. L. J. Am. Soc. Mass Spectrom. 2002, 13, 1418-1426.
34. (i) Hirose, T.; Ohtani, T.; Muramatsu, H.; Tanaka, A. Photochem. Photobiol. 2002, 76, 123-126.
35. (j) JongMin, K.; Hiroshi, M.; HeaYeon, L.; Tomoji, K. FEBS Lett. 2003, 555, 611-615.
36. (k) Sato, K.; Greenberg, M. M. J. Am. Chem. Soc. 2005, 127, 2806-2807.
37. Other methods: (l) Fukui, K.; Morimoto, M.; Segawa, H.; Tanaka, K.; Shimidzu, T. Bioconjugate Chem. 1996, 7, 349-355.
38. (m) Matray, J. T.; Kool, E. T. Nature 1999, 399, 704-708.
39. (n) Rachofsky, E. L.; Seibert, E.; Stivers, J. T.; Osman, R.; Alexander Ross, J. B. Biochemistry 2001, 40, 957-967.
40. (o) Brotschi, C.; Häberli, A.; Leumann, C. J. Angew. Chem. 2001, 40, 3012-3014.
41. (p) Yoshimoto, K.; Nishizawa, S.; Minagawa, M.; Teramae, N. J. Am. Chem. Soc. 2003, 125, 8982-8983.
42. (q) Valis, L.; Amann N.; Wagenknecht, H.-A. Org. Biomol. Chem. 2005, 3, 36-38.
43. We are currently pursuing a high-resolution NMR structural elucidation of the modified duplex.